Atom Investors’s Praxis Precision Medicines PRAX Stock Holding History

Atom Investors’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.83M	Buy	21,196 +4,709	+29%	+$1.46M	0.49%	35
2025 Q4	$4.86M	Buy	+16,487	New	+$3.07M	0.39%	70
2025 Q2	–	Sell	-19,779	Closed	-$749K	–	749
2025 Q1	$749K	Buy	+19,779	New	+$1.24M	0.09%	247
2024 Q2	–	Sell	-34,867	Closed	-$2.13M	–	625
2024 Q1	$2.13M	Buy	34,867 +4,830	+16%	+$217K	0.27%	121
2023 Q4	$669K	Buy	30,037 +23,185	+338%	+$418K	0.12%	231
2023 Q3	$176K	Buy	+6,852	New	+$130K	0.04%	384
2023 Q1	–	Sell	-1,773	Closed	-$63.3K	–	306
2022 Q4	$63.3K	Buy	+1,773	New	+$55.3K	0.03%	203

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Atom Investors's PRAX Position: Q1 2026 in Review

Atom Investors increased its Praxis Precision Medicines (PRAX) stake by 29% in Q1 2026, buying an estimated $1.46M and bringing the position to 21,196 shares worth $6.83M. The position accounts for 0.49% of the portfolio, ranked #35.

Atom Investors first reported a position in PRAX in Q4 2022 and has held it in 7 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

Atom Investors held 21,196 shares of Praxis Precision Medicines worth $6.83M as of Q1 2026.
Atom Investors bought 4,709 Praxis Precision Medicines shares in Q1 2026, an estimated $1.46M.
Praxis Precision Medicines made up 0.49% of Atom Investors's portfolio in Q1 2026, its #35 holding.
Atom Investors first reported a position in Praxis Precision Medicines in Q4 2022 and has held it in 7 quarters since.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.